A Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for Moderate to Severe Psoriasis

NCT00302445 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: Efalizumab
DEVICE: Narrow Band Phototherapy

Sponsor

Derm Research, PLLC

Collaborators

[object Object]
[object Object]